PeptideAgentAsk PeptideAgent
Peptide guide · Recovery

Thymosin Beta-4: the evidence, status, and research questions.

Thymosin Beta-4 guide to human and preclinical evidence, research uses, FDA status, sport status, primary sources, and key limits.

Published Evidence reviewed August 8, 20263 inspectable sources7 min read
01What is Thymosin Beta-4?02What is the evidence for Thymosin Beta-4?03What is Thymosin Beta-4 being studied for?04Is Thymosin Beta-4 FDA approved?05Is Thymosin Beta-4 prohibited in sport?06What are the evidence limits for Thymosin Beta-4?

EVIDENCE TAKEAWAY

The short answer.

Thymosin beta-4 has early human development work and extensive preclinical biology, but that record does not establish routine systemic recovery use or equivalence to TB-500 products.

WHAT IS THYMOSIN BETA-4?

Start with identity.

A naturally occurring actin-binding peptide studied in tissue repair and regenerative biology.

Entity type
Native peptide
Research category
Recovery
Names and aliases
Thymosin Beta-4

HUMAN VS PRECLINICAL

What evidence exists for Thymosin Beta-4?

HUMAN EVIDENCE
2/5 · Early clinical research

Phase 1 systemic exposure and small phase 2 topical ophthalmic studies exist, but no broad recovery indication is established.

PRECLINICAL EVIDENCE
4/5 · Extensive repair biology

Actin binding, cell migration, angiogenesis, and repair models form a substantial preclinical literature.

RESEARCH INTENT

What is Thymosin Beta-4 being studied for?

Current source-backed research areas include the topics below. Inclusion means the area is being investigated; it does not establish a treatment benefit.

  • 01Corneal repair
  • 02Tissue repair
  • 03Actin biology
  • 04Cell migration

U.S. REGULATORY STATUS

Is Thymosin Beta-4 FDA approved?

No FDA-approved thymosin beta-4 drug product identified in the August 2026 source snapshot.

SPORT STATUS

Is Thymosin Beta-4 prohibited in sport?

Prohibited at all times under the 2026 WADA List (S2), which names thymosin beta-4 and derivatives such as TB-500.

Anti-doping rules and product ingredients can change. Athletes should verify the current official list and the exact product before making a real decision.

EVIDENCE LIMITS

What can the current record not establish?

COMMON SEARCH INTENTS

Reviewed questions about Thymosin Beta-4.

Evidence

What is the evidence for Thymosin Beta-4?

Thymosin beta-4 has early human development work and extensive preclinical biology, but that record does not establish routine systemic recovery use or equivalence to TB-500 products.

3 sources Research

What is Thymosin Beta-4 being studied for?

Current source-backed research areas include Corneal repair, Tissue repair, Actin biology, Cell migration. These areas describe investigation, not established personal benefit.

3 sources FDA status

Is Thymosin Beta-4 FDA approved?

Current U.S. status for Thymosin Beta-4: No FDA-approved thymosin beta-4 drug product identified in the August 2026 source snapshot.

3 sources Sport status

Is Thymosin Beta-4 prohibited in sport?

Current sport-status snapshot for Thymosin Beta-4: Prohibited at all times under the 2026 WADA List (S2), which names thymosin beta-4 and derivatives such as TB-500.

3 sources Evidence limits

What are the main evidence limits for Thymosin Beta-4?

Full-length thymosin beta-4, recombinant products, topical formulations, and TB-500 are not interchangeable evidence entities.

3 sources

PRIMARY AND OFFICIAL SOURCES

Inspect the research behind this guide.